Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 2 | - | - | |
Psoriasis vulgaris | Preclinical | FR | 03 Nov 2016 | |
Plaque psoriasis | Preclinical | FR | 12 Oct 2015 |
Phase 2 | 24 | placebo (CD10367 Placebo Pretreated) | nkvoeicnwc(oppjuvqdaf) = xfggkozxgy gpoaadeqrj (ekqidjyxba, ajhvevnlsv - mxujxkbclm) View more | - | 19 Sep 2024 | ||
(CD10367 3% Pretreated) | nkvoeicnwc(oppjuvqdaf) = exzkokebsw gpoaadeqrj (ekqidjyxba, awwqkngtna - zmruooqccb) View more |